MurrayHRosenthalDOFAPA

PubMed

• 14 citations
  Determination of medication cutoff values in a pain patient population
  Amadeo J. Pesce, Cameron West, Robert West, Bridgit Crews, Charles Mikel, Murray Rosenthal, Perla Almazon, Sergey Latyshev> ;Journal of Opioid Management. 2018 Jan 15
• 9 citations
  Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine.
  Amadeo J. Pesce, Cameron West, Elizabeth Gonzales, Murray Rosenthal, Robert West, Charles Mikel, Perla Almazan, Sergey Latyshev, Paul S. Horn> ;Pain Physician. 2012 Sep 1
• 22 citations
  Therapeutic monitoring of benzodiazepines in the management of pain: Current limitations of point of care immunoassays suggest testing by mass spectrometry to assure a...
  Charles Mikel, Amadeo J. Pesce, Murray Rosenthal, Cameron West> ;Clinica Chimica Acta; International Journal of Clinical Chemistry. 2012 Aug 16
• 8 citations
  Determination of illicit drug cutoff values in a pain patient population.
  Robert West, Amadeo J. Pesce, Bridgit Crews, Charles Mikel, Murray Rosenthal, Perla Almazan, Sergey Latyshev, Cameron West> ;Clinica Chimica Acta; International Journal of Clinical Chemistry. 2011 Aug 17
• 23 citations
  Illicit drug use in the pain patient population decreases with continued drug testing.
  Amadeo J. Pesce, Cameron West, Murray Rosenthal, Charles Mikel, Robert West, Bridgit Crews, Perla Almazan, Sergey Latyshev, Paul S. Horn> ;Pain Physician. 2011 Mar 1
• 15 citations
  Anomalous observations of hydrocodone in patients on oxycodone.
  Robert West, Cameron West, Bridgit Crews, Perla Almazan, Sergey Latyshev, Murray Rosenthal, Amadeo J. Pesce, Charles Mikel> ;Clinica Chimica Acta; International Journal of Clinical Chemistry. 2011 Jan 14
• Improvement of pain physicians' practices of opioid management: population-based urinary excretion data.
  Pesce A, Crews B, Latyshev S, Mikel C, Almazan P, West R, Rosenthal M, West C> ;J Opioid Manag. 2011-01-01
• An improved method of determining ethanol use in a chronic pain population.
  Crews B, West R, Gutierrez R, Latyshev S, Mikel C, Almazan P, Pesce A, West C, Rosenthal M> ;J Opioid Manag. 2011-01-01
• 26 citations
  Marijuana correlates with use of other illicit drugs in a pain patient population.
  Amadeo J. Pesce, Cameron West, Murray Rosenthal, Robert West, Bridgit Crews, Charles Mikel, Perla Almazan, Sergey Latyshev, Paul S. Horn> ;Pain Physician. 2010 May 1
• 70 citations
  An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.
  Amadeo J. Pesce, Murray Rosenthal, Robert West, Cameron West, Bridgit Crews, Charles Mikel, Perla Almazan, Sergey Latyshev> ;Pain Physician. 2010 May 1
• 32 citations
  Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population.
  Robert West, Amadeo J. Pesce, Cameron West, Bridgit Crews, Charles Mikel, Perla Almazan, Murray Rosenthal, Sergey Latyshev> ;Pain Physician. 2010 Jan 1
• Reference intervals: a novel approach to detect drug abuse in a pain patient population.
  Pesce A, West C, West R, Crews B, Mikel C, Almazan P, Latyshev S, Rosenthal M, Horn P> ;J Opioid Manag. 2010-01-01
• Observations of medication compliance by measurement of urinary drug concentrations in a pain management population.
  West R, Pesce A, West C, Crews B, Mikel C, Rosenthal M, Almazan P, Latyshev S> ;J Opioid Manag. 2010-01-01
• 56 citations
  Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.
  Serge Sevy, Murray H Rosenthal, Jose Alvir, Sabina Meyer, Hema Visweswaraiah, Handan Gunduz-Bruce, Nina R. Schooler> ;The Journal of Clinical Psychiatry. 2005 Jul 15
• 85 citations
  Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.
  Murray H Rosenthal> ;The Journal of Clinical Psychiatry. 2003 Oct 15
• 131 citations
  Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder: A Preliminary Double-Blind, Placebo-Controlled Study
  Charles DeBattista, Karl Doghramji, Matthew Menza, Murray H Rosenthal, Ronald R Fieve> ;The Journal of Clinical Psychiatry. 2003 Sep 15
• 1 citations
  Barriers to diagnosis, advances in therapy.
  Murray H. Rosenthal> ;The Journal of the American Osteopathic Association. 2003 Aug 1
• 9 citations
  The challenge of comorbid disorders in patients with depression.
  Murray H. Rosenthal> ;The Journal of the American Osteopathic Association. 2003 Aug 1
• Long-term treatment effects of vitamin E for tardive dyskinesia.
  Adler LA, Edson R, Lavori P, Peselow E, Duncan E, Rosenthal M, Rotrosen J> ;Biol. Psychiatry. 1998-06-15
• Women and infertility.
  Rosenthal M> ;Psychopharmacol Bull. 1998-01-01
• Trazodone for antidepressant-associated insomnia.
  Nierenberg AA, Adler LA, Peselow E, Zornberg G, Rosenthal M> ;Am J Psychiatry. 1994-07-01
• Adverse interaction of cyproheptadine with serotonergic antidepressants.
  Katz RJ, Rosenthal M> ;J Clin Psychiatry. 1994-07-01
• Vitamin E treatment of tardive dyskinesia.
  Adler LA, Peselow E, Rotrosen J, Duncan E, Lee M, Rosenthal M, Angrist B> ;Am J Psychiatry. 1993-09-01
• Serotonergic (5-HT2) mediation of anxiety-therapeutic effects of serazepine in generalized anxiety disorder.
  Katz RJ, Landau PS, Lott M, Bystritsky A, Diamond B, Hoehn-Saric R, Rosenthal M, Weise C> ;Biol. Psychiatry. 1993-01-01
• A controlled comparison of the effects of propranolol, benztropine, and placebo on akathisia: an interim analysis.
  Adler LA, Peselow E, Rosenthal M, Angrist B> ;Psychopharmacol Bull. 1993-01-01
• Join now to see all